特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
959799

脂質降下薬の世界市場レポート (2020-2030年):COVID 19による影響と回復

Hypolipidemics Global Market Report 2020-30: Covid 19 Impact and Recovery

出版日: | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.35円
脂質降下薬の世界市場レポート (2020-2030年):COVID 19による影響と回復
出版日: 2020年09月09日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の脂質降下薬市場について調査分析し、市場概要、市場規模と予測、セグメント別の市場分析、地域・国別の市場分析、競合情勢などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 脂質降下薬市場の特徴

第3章 脂質降下薬の市場規模と成長

  • 世界の脂質降下薬市場実績 (金額ベース)
    • 市場の成長要因
    • 市場の抑制要因
  • 世界の脂質降下薬市場予測 (金額ベース)
    • 市場の成長要因
    • 市場の抑制要因

第4章 脂質降下薬市場のセグメンテーション

  • 世界の脂質降下薬市場、実績と予測 (金額ベース) :製品タイプ別
    • コール酸レギュレーター
    • HMG-CoAレダクターゼ阻害剤
    • アデニル酸シクラーゼ阻害剤
    • ニコチン酸薬
    • その他
  • 世界の脂質降下薬市場、実績と予測 (金額ベース) :アプリケーション別
    • 病院
    • クリニック
    • 薬局
    • 心臓血管学

第5章 脂質降下薬市場:地域別および国別分析

  • 世界の脂質降下薬市場、実績と予測 (金額ベース) :地域別
  • 世界の脂質降下薬市場、実績と予測 (金額ベース) :国別

第6章 アジア太平洋の脂質降下薬市場

  • 市場概要
  • 市場実績と予測 (金額ベース) :製品タイプ別
  • 市場実績と予測 (金額ベース) :アプリケーション別

第7章 中国の脂質降下薬市場

第8章 インドの脂質降下薬市場

第9章 日本の脂質降下薬市場

第10章 オーストラリアの脂質降下薬市場

第11章 インドネシアの脂質降下薬市場

第12章 韓国の脂質降下薬市場

第13章 西欧の脂質降下薬市場

第14章 英国の脂質降下薬市場

第15章 ドイツの脂質降下薬市場

第16章 フランスの脂質降下薬市場

第17章 東欧の脂質降下薬市場

第18章 ロシアの脂質降下薬市場

第19章 北米の脂質降下薬市場

第20章 米国の脂質降下薬市場

第21章 南米の脂質降下薬市場

第22章 ブラジルの脂質降下薬市場

第23章 中東の脂質降下薬市場

第24章 アフリカの脂質降下薬市場

第25章 脂質降下薬市場の競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • ABBOTT LABORATORIES LIMITED
    • Apotex Fermentation Inc.
    • BIOCON LIMITED IN Bangalore
    • Cadila Healthcare Limited
    • Chunghwa Chem Syn& Biotech Co., Ltd

第26章 脂質降下薬市場における主要な合併と買収

第27章 脂質降下薬の市場動向と戦略

第28章 製品パイプライン分析

第29章 脂質降下薬市場の将来展望と潜在力分析

第30章 付録

目次

Hypolipidemics Global Market Report 2020-30: Covid 19 Impact and Recovery from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global hypolipidemics market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the hypolipidemics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hypolipidemics Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered: 1) By Product Type: Cholic Acid Regulator; HMG-CoA Reductase Inhibitors; Adenylate Cyclase Inhibitors; Nicotinic Acid Drugs; Others

2) By Application: Hospital; Clinics; Pharmacy; Cardiovasology

Companies Mentioned: ABBOTT LABORATORIES LIMITED; Apotex Fermentation Inc.; BIOCON LIMITED; Cadila Healthcare Limited; Chunghwa Chem Syn& Biotech

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Hypolipidemic Drugs Market Characteristics

3. Hypolipidemic Drugs Market Size And Growth

  • 3.1. Global Hypolipidemic Drugs Historic Market, 2015-2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Hypolipidemic Drugs Forecast Market, 2019-2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Hypolipidemic Drugs Market Segmentation

  • 4.1. Global Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Cholic Acid Regulator
    • HMG-CoA Reductase Inhibitors
    • Adenylate Cyclase Inhibitors
    • Nicotinic Acid Drugs
    • Others
  • 4.2. Global Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
    • Hospital
    • Clinics
    • Pharmacy
    • Cardiovasology

5. Hypolipidemic Drugs Market Regional And Country Analysis

  • 5.1. Global Hypolipidemic Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Hypolipidemic Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Hypolipidemic Drugs Market

  • 6.1. Asia-Pacific Hypolipidemic Drugs Market Overview
  • 6.2. Asia-Pacific Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Hypolipidemic Drugs Market

  • 7.1. China Hypolipidemic Drugs Market Overview
  • 7.2. China Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Hypolipidemic Drugs Market

  • 8.1. India Hypolipidemic Drugs Market Overview
  • 8.2. India Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Hypolipidemic Drugs Market

  • 9.1. Japan Hypolipidemic Drugs Market Overview
  • 9.2. Japan Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Hypolipidemic Drugs Market

  • 10.1. Australia Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Hypolipidemic Drugs Market

  • 11.1. Indonesia Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Hypolipidemic Drugs Market

  • 12.1. South Korea Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Hypolipidemic Drugs Market

  • 13.1. Western Europe Hypolipidemic Drugs Market Overview
  • 13.2. Western Europe Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Hypolipidemic Drugs Market

  • 14.1. UK Hypolipidemic Drugs Market Overview
  • 14.2. UK Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Hypolipidemic Drugs Market

  • 15.1. Germany Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Hypolipidemic Drugs Market

  • 16.4. France Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Hypolipidemic Drugs Market

  • 17.1. Eastern Europe Hypolipidemic Drugs Market Overview
  • 17.2. Eastern Europe Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Hypolipidemic Drugs Market

  • 18.1. Russia Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Hypolipidemic Drugs Market

  • 19.1. North America Hypolipidemic Drugs Market Overview
  • 19.2. North America Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Hypolipidemic Drugs Market

  • 20.1. USA Hypolipidemic Drugs Market Overview
  • 20.2. USA Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Hypolipidemic Drugs Market

  • 21.1. South America Hypolipidemic Drugs Market Overview
  • 21.2. South America Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Hypolipidemic Drugs Market

  • 22.1. Brazil Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Hypolipidemic Drugs Market

  • 23.1. Middle East Hypolipidemic Drugs Market Overview
  • 23.2. Middle East Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Hypolipidemic Drugs Market

  • 24.1. Africa Hypolipidemic Drugs Market Overview
  • 24.2. Africa Hypolipidemic Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Hypolipidemic Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Hypolipidemic Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Hypolipidemic Drugs Market Competitive Landscape
  • 25.2. Hypolipidemic Drugs Market Company Profiles
    • 25.2.1. ABBOTT LABORATORIES LIMITED
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Apotex Fermentation Inc.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. BIOCON LIMITED IN Bangalore
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Cadila Healthcare Limited
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Chunghwa Chem Syn& Biotech Co., Ltd
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Hypolipidemic Drugs Market

27. Hypolipidemic Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Hypolipidemic Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.